HIV/AIDS: Transmission, Testing, Treatment & Stigma Reduction
What Is HIV/AIDS?
- HIV (Human Immunodeficiency Virus): Retrovirus infecting CD4+ T cells → progressive immune decline.
- AIDS (Acquired Immunodeficiency Syndrome): Clinical stage defined by CD4 <200 cells/μL or AIDS-defining illness (opportunistic infections, malignancies).
Transmission Routes
| Route | Risk per Act (Est.) | Prevention |
|---|---|---|
| Anal receptive sex | 1.4% (1/71) | Condoms, PrEP, TasP, lubricant |
| Anal insertive sex | 0.11% (1/909) | Condoms, PrEP, TasP |
| Vaginal receptive sex | 0.08% (1/1250) | Condoms, PrEP, TasP |
| Vaginal insertive sex | 0.04% (1/2500) | Condoms, PrEP, TasP |
| Needle sharing (IDU) | 0.63% (1/159) | Syringe services, MOUD, PrEP |
| Mother-to-child (no intervention) | 15–45% | ART in pregnancy, C-section if VL>1000, no breastfeeding (US) |
| Blood transfusion (screened) | <1/1,000,000 | Nucleic acid testing (NAT) screening |
No risk: Saliva, sweat, tears, urine, feces (unless blood-contaminated), casual contact, kissing (unless open sores), sharing food/toilets, insects.
Testing
- 4th gen Ag/Ab: Detects p24 antigen + antibodies; window period 18–45 days.
- NAT (RNA): Window 10–33 days; used for acute infection, blood screening.
- Rapid Ab: Window 23–90 days; point-of-care.
- Recommendation: Everyone 13–64 at least once; high-risk annually; pregnant each pregnancy.
Treatment: ART (Antiretroviral Therapy)
- Goal: Viral suppression (<50 copies/mL) → immune recovery, zero transmission risk (U=U: Undetectable = Untransmittable).
- Regimens: 2-drug (DTG/3TC, DRV/3TC) or 3-drug (BIC/FTC/TAF, DTG/ABC/3TC, DRV/c/FTC/TAF). Individualized.
- Initiation: Rapid start (same day) preferred.
- Monitoring: VL q3–6mo, CD4 q3–6mo (stop if VL suppressed & CD4>250), resistance if virologic failure.
Prevention
- PrEP: TDF/FTC (daily), TAF/FTC (daily, MSM/TGW), Cabotegravir LA (bimonthly IM). >99% effective with adherence.
- PEP: 28-day ART within 72h of exposure.
- TasP: Treat positive partners to undetectable.
- Syringe services, condoms, voluntary medical male circumcision (VMMC).
Stigma & Discrimination
- Internalized, enacted, anticipated stigma → delayed testing, poor adherence, mental health burden.
- Legal: 35 US states criminalize HIV non-disclosure/exposure (many outdated).
- Combat: U=U messaging, person-first language ("person with HIV"), policy reform, community empowerment.
HIV is a manageable chronic condition. Early testing, immediate ART, and stigma-free care save lives and stop transmission.
HIV & AIDS - Related Articles
- HIV Vaccine Development: Current Status, Challenges, and Hope
- HIV Transmission Facts: Not Spread Through Digestion
- HIV Window Period: How Soon Can HIV Be Detected?
- Understanding and Overcoming Fear of HIV Testing: A Guide
- How HIV Disrupts Homeostasis: Immune, Neurologic, Metabolic & Organ Effects
- HIV Survival in Tap Water: Zero Risk — Here's Why
- Understanding AIDS and HIV Transmission: What You Need to Know
